Pharmacogenomics - Improving Health and Safety
$19.95 Buy and instantly download this paper now
This paper examines a new approach to drug treatment known as pharmacogenomics, which focuses on eliminating the side-effects of pharmaceutical treatment. Additionally, the paper describes how this approach is based on an individual's genetic make-up and should therefore be more effective to treating illness and disease. The paper further notes how pharmacogenomics would be used to also prevent disease, addressing conditions which have previously been seen as chronic and serve to lengthen and improve human life. Next, the paper explores how this discipline serves to improve health safety with prospects for the improvement of treatment outcomes. The paper concludes with a look at the Human Genome Project and how it relates to pharmacogenomics.
From the Paper:"The field would be the outcome of two important contexts for medical treatment improvement. A more detailed comprehension of both chemical physiology and genetic makeup have offered remarkable new insights into ways to remove human beings from suffering, act to preventatively address conditions which have previously been seen as chronic and serve to lengthen and improve human life. Indeed, in just the space of a decade, science has made absolutely monumental strides in terms of identifying the building blocks of human life. From the mapping of the human genome, a project which was completed in 2003, to the day's top headlines on the subject of stem cell research in the political and philosophical arenas, the improvement of our grasp on human genetics has opened exciting new doors for medicine and science."
Sample of Sources Used:
- Bates, D.; Phillips, K.; Alldredge, B.; Issa, A. & Huskamp, H. (2005). Can Pharmacogenomics Improve Drug Safety? NLM Gateway. Online at http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=103623628.html
- Burczynski, M.E. & Dorner, A.J. (2006). Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies. Pharmacogenomics, 7(2), 187-202.
- Evans, W.E. & McLeod, H.L. (2003). Pharmacogenomics--Drug Disposition, Drug Targets, and Side Effects. Drug Therapy, 348, 538-549.
- Evans, W.E. & Relling, M.V. (1999). Pharmacogenomics: Translating Functional Genomics Into Rational Therapeutics. Science, 286(5439), 487-491.
- Evans, W.E. & Relling, M.V1. (2004). Moving Towards Individualized Medicine With Pharmacogenomics. Nature, 429, 424-468.
Cite this Term Paper:
Pharmacogenomics - Improving Health and Safety (2012, January 29) Retrieved July 12, 2020, from https://www.academon.com/term-paper/pharmacogenomics-improving-health-and-safety-150206/
"Pharmacogenomics - Improving Health and Safety" 29 January 2012. Web. 12 July. 2020. <https://www.academon.com/term-paper/pharmacogenomics-improving-health-and-safety-150206/>